These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12200142)

  • 1. Interaction of oncogenic papillomavirus E6 proteins with fibulin-1.
    Du M; Fan X; Hong E; Chen JJ
    Biochem Biophys Res Commun; 2002 Aug; 296(4):962-9. PubMed ID: 12200142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins.
    Park JS; Kim EJ; Lee JY; Sin HS; Namkoong SE; Um SJ
    Int J Cancer; 2001 Mar; 91(6):822-7. PubMed ID: 11275986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human papillomavirus 16 E6 protein binds to tumor necrosis factor (TNF) R1 and protects cells from TNF-induced apoptosis.
    Filippova M; Song H; Connolly JL; Dermody TS; Duerksen-Hughes PJ
    J Biol Chem; 2002 Jun; 277(24):21730-9. PubMed ID: 11934887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein.
    Chen JJ; Reid CE; Band V; Androphy EJ
    Science; 1995 Jul; 269(5223):529-31. PubMed ID: 7624774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential drugs against cervical cancer: zinc-ejecting inhibitors of the human papillomavirus type 16 E6 oncoprotein.
    Beerheide W; Bernard HU; Tan YJ; Ganesan A; Rice WG; Ting AE
    J Natl Cancer Inst; 1999 Jul; 91(14):1211-20. PubMed ID: 10413422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53.
    Martinez-Zapien D; Ruiz FX; Poirson J; Mitschler A; Ramirez J; Forster A; Cousido-Siah A; Masson M; Vande Pol S; Podjarny A; Travé G; Zanier K
    Nature; 2016 Jan; 529(7587):541-5. PubMed ID: 26789255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus oncoprotein E6 binds to the C-terminal region of human minichromosome maintenance 7 protein.
    Kukimoto I; Aihara S; Yoshiike K; Kanda T
    Biochem Biophys Res Commun; 1998 Aug; 249(1):258-62. PubMed ID: 9705868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of cottontail rabbit papillomavirus E6 oncoproteins with the hDlg/SAP97 tumor suppressor.
    Du M; Fan X; Hanada T; Gao H; Lutchman M; Brandsma JL; Chishti AH; Chen JJ
    J Cell Biochem; 2005 Apr; 94(5):1038-45. PubMed ID: 15669058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV E6 and MAGUK protein interactions: determination of the molecular basis for specific protein recognition and degradation.
    Thomas M; Glaunsinger B; Pim D; Javier R; Banks L
    Oncogene; 2001 Sep; 20(39):5431-9. PubMed ID: 11571640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of p53 DNA binding by human papillomavirus E6 proteins.
    Lechner MS; Laimins LA
    J Virol; 1994 Jul; 68(7):4262-73. PubMed ID: 8207801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational analysis of HPV-18 E6 identifies domains required for p53 degradation in vitro, abolition of p53 transactivation in vivo and immortalisation of primary BMK cells.
    Pim D; Storey A; Thomas M; Massimi P; Banks L
    Oncogene; 1994 Jul; 9(7):1869-76. PubMed ID: 8208532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational analysis of human papillomavirus type 16 E6 protein: transforming function for human cells and degradation of p53 in vitro.
    Nakagawa S; Watanabe S; Yoshikawa H; Taketani Y; Yoshiike K; Kanda T
    Virology; 1995 Oct; 212(2):535-42. PubMed ID: 7571423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The domain of p53 required for binding HPV 16 E6 is separable from the degradation domain.
    Mansur CP; Marcus B; Dalal S; Androphy EJ
    Oncogene; 1995 Feb; 10(3):457-65. PubMed ID: 7845670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene.
    Spitkovsky D; Aengeneyndt F; Braspenning J; von Knebel Doeberitz M
    Oncogene; 1996 Sep; 13(5):1027-35. PubMed ID: 8806692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular Analysis of the Interaction between the Human Papillomavirus Type 16 E6 Oncoprotein and Inhibitory Peptides.
    Stutz C; Reinz E; Honegger A; Bulkescher J; Schweizer J; Zanier K; Travé G; Lohrey C; Hoppe-Seyler K; Hoppe-Seyler F
    PLoS One; 2015; 10(7):e0132339. PubMed ID: 26151636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Cdk1 in the p53-independent abrogation of the postmitotic checkpoint by human papillomavirus E6.
    Zhang W; Liu Y; Zhao N; Chen H; Qiao L; Zhao W; Chen JJ
    J Virol; 2015 Mar; 89(5):2553-62. PubMed ID: 25520504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of human papillomavirus type 18 (HPV-18) E6-mediated degradation of p53 in vitro and in vivo reveals significant differences based on p53 structure and cell type but little difference with respect to mutants of HPV-18 E6.
    Gardiol D; Banks L
    J Gen Virol; 1998 Aug; 79 ( Pt 8)():1963-70. PubMed ID: 9714244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of serum- and calcium-induced terminal differentiation of human keratinocytes by HPV 16 E6: study of the association with p53 degradation, inhibition of p53 transactivation, and binding to E6BP.
    Sherman L; Itzhaki H; Jackman A; Chen JJ; Koval D; Schlegel R
    Virology; 2002 Jan; 292(2):309-20. PubMed ID: 11878933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structures of a human papillomavirus (HPV) E6 polypeptide bound to MAGUK proteins: mechanisms of targeting tumor suppressors by a high-risk HPV oncoprotein.
    Zhang Y; Dasgupta J; Ma RZ; Banks L; Thomas M; Chen XS
    J Virol; 2007 Apr; 81(7):3618-26. PubMed ID: 17267502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus oncogenic E6 protein regulates human β-defensin 3 (hBD3) expression via the tumor suppressor protein p53.
    DasGupta T; Nweze EI; Yue H; Wang L; Jin J; Ghosh SK; Kawsar HI; Zender C; Androphy EJ; Weinberg A; McCormick TS; Jin G
    Oncotarget; 2016 May; 7(19):27430-44. PubMed ID: 27034006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.